Sugi Predict

Sugi Predict / Compounds / SCHEMBL1055293

SCHEMBL1055293

SCHEMBL1055293

COc1ccc(OC)c(CCl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.61
▸ ADRA1A P35348 1/20 0.61
▸ TAAR1 Q96RJ0 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.58
▸ HTR2A P28223 1/20 0.58
▸ CA12 O43570 1/20 0.56
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ CA7 P43166 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ CA14 Q9ULX7 1/20 0.56
▸ AOC3 Q16853 1/20 0.54
▸ MTNR1A P48039 1/20 0.51
▸ MTNR1B P49286 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.49
▸ GFER P55789 1/20 0.49
▸ APLNR P35414 1/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ KMT2A Q03164 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27566990 0.98 IDO1 (0.59) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL5042302 0.98 IDO1 (0.59) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL30284879 0.89 IDO1 (0.50) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL31068484 0.89 IDO1 (0.50) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL7060410 0.84 ADRA1A (0.68) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL590943 0.83 APLNR (0.63) IDO1ADRA1ATAAR1HTR2ACA12
SCHEMBL9676713 0.83 ALDH1A1 (0.51) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL5252421 0.83 IDO1 (0.66) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL3205585 0.82 HCRTR1 (0.46) IDO1ADRA1ATAAR1HSD17B10HTR2A
SCHEMBL805159 0.81 HSD17B10 (0.65) IDO1ADRA1ATAAR1HSD17B10HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117384019-A Synthesis method of 2, 5-dihydroxyl terephthalaldehyde 苏州大学 2024-01-12 — — CN claimed
CN-111909389-B Covalent organic framework material and preparation method and application thereof 山东师范大学 2022-04-15 — — CN claimed
CN-112538025-A Preparation method of fluorine-containing compound for hydrophobic surface treatment agent 湖北福力德鞋业有限责任公司 2021-03-23 — — CN claimed
CN-111909389-A Covalent organic framework material and preparation method and application thereof 山东师范大学 2020-11-10 — — CN claimed
CN-102146056-A N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives UNIV TSINGHUA GRADUATE SCHOOL 2011-08-10 — — CN claimed
CN-117384019-A Synthesis method of 2, 5-dihydroxyl terephthalaldehyde 苏州大学 2024-01-12 — — CN disclosed
CN-117384019-A Synthesis method of 2, 5-dihydroxyl terephthalaldehyde 苏州大学 2024-01-12 — — CN disclosed
US-11612598-B2 Compounds and methods for the treatment of cancer THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-03-28 — — US disclosed
CN-111909389-B Covalent organic framework material and preparation method and application thereof 山东师范大学 2022-04-15 — — CN disclosed
CN-112538025-A Preparation method of fluorine-containing compound for hydrophobic surface treatment agent 湖北福力德鞋业有限责任公司 2021-03-23 — — CN disclosed
CN-112321412-A Preparation method of 2, 5-dimethoxy phenylacetic acid 爱斯特（成都）生物制药股份有限公司 2021-02-05 — — CN disclosed
CN-112239402-A Preparation method of 2, 5-dimethoxy phenylacetic acid 爱斯特（成都）生物制药股份有限公司 2021-01-19 — — CN disclosed
EP-0326379-A2 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO., LTD. (JP) 1989-08-02 — — EP disclosed
US-4788010-A Amino substituted benzenepropanols E. R. SQUIBB & SONS, INC. (US) 1988-11-29 — — US disclosed
EP-0046710-B1 PREPARATION OF AMINOACETONITRILE DERIVATIVES MERRELL TORAUDE ET COMPAGNIE (FR) 1984-06-13 — — EP disclosed
US-4446323-A Tetra- and hexa-hydropyrrolo(1,2-a)quinoxaline and azaquinoxaline derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1984-05-01 — — US disclosed
US-4405530-A Process for preparing fluorinated amino-nitriles MERRELL TORAUDE ET COMPAGNIE (FR) 1983-09-20 — — US disclosed
US-4342780-A 2-AMINO-2-FLUOROMETHYL-3-(SUBSTITUTED) PHENYL PROPIONIC ACIDS AND DERIVATIVES COADMINISTERED WITH DOPAMINE MERRELL-TORAUDE ET CIE (FR) 1982-08-03 — — US disclosed
EP-0046710-A1 Preparation of aminoacetonitrile derivatives MERRELL TORAUDE ET COMPAGNIE (FR) 1982-03-03 — — EP disclosed
US-3947337-A α,ω-Diarylpolyene photosensitizers for sulfonylazide polymers THE UPJOHN COMPANY (US) 1976-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11612598-B2 Compounds and methods for the treatment of cancer CASP3, BAX, CASP6 IDO1 3217/4885ADRA1A 4870/4885TAAR1 4744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.